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Abstract
Background: Surveillance colonoscopy is commonly recommended following potentially curative
surgery for colorectal cancer. We determined factors associated with patients undergoing a least
one colonoscopy within five years of surgery.
Methods: In this historical cohort study, data on 3918 patients age 30 years or older residing in
Alberta, Canada, who had undergone a potentially curative surgical resection for local or regional
stage colorectal cancer between 1983 and 1995 were obtained from the provincial cancer registry,
ministry of health and cancer clinic charts. Kaplan-Meier estimates of the probability of undergoing
a post-operative colonoscopy were calculated for patient, tumor and treatment-related variables
of interest.
Results:  A colonoscopy was performed within five years of surgery in 1979 patients. The
probability of undergoing a colonoscopy for those diagnosed in the 1990s was greater than for
those diagnosed earlier (0.65 vs 0.55, P < 0.0001). The majority of the difference was seen at one-
year following surgery, consistent with changes in surveillance practices. Those most likely to
undergo a colonoscopy were those under age 70 (0.74 vs 0.50 for those age 70 – 79, P < 0.0001),
who underwent a pre-operative colonoscopy (0.69 vs 0.54, P < 0.0001), and who underwent a
resection with reanastomosis (0.62 vs 0.47 for abdominoperineal resection, P < 0.0001) by a
surgeon who performs colonoscopies (0.68 vs 0.54, P < 0.0001).
Conclusions: The majority of patients undergo colonoscopy following colorectal cancer surgery.
However, there are important variations in surveillance practices across different patient and
treatment characteristics.
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Background
Colorectal cancer is a major cause of cancer-associated
morbidity and mortality. Surgical resection is the treat-
ment of choice for colorectal cancer and is often curative
for early stage tumours. Patients with local lymph node
metastases have a high rate of local and distant recurrence
that can be reduced with adjuvant chemotherapy and/or
radiotherapy. However, nearly 40 – 50% of patients who
undergo curative intent surgery with or without adjuvant
therapy will die in the following 5 years from local or dis-
tant recurrence[1]. In addition, patients who have had
one colorectal cancer are also at increased risk of develop-
ing a second primary colorectal cancer[2,3].
Because of the risks of local or distant recurrence and new
cancers, it is commonly recommended that patients
undergo a variety of tests, including visualization of the
remaining colon, over the months to years after their sur-
gery to detect disease early, prior to the development of
clinical symptoms, enhancing the success of effective, cur-
ative therapy [4-8]. With the development of fiber-optic
colonoscopes in the 1970's, most recommendations
included colonoscopy as the primary method for examin-
ing the residual colon to detect intraluminal recurrence or
new cancers.
Although controversy remains over how effective surveil-
lance strategies are in reducing colorectal cancer mortality,
some form of surveillance is almost uniformly recom-
mended by experts, specialist organizations and cancer
societies. However, there has been growing recognition
that very intensive follow-up has not provided as substan-
tial a survival benefit as initially hoped [9-11]. Yearly
colonoscopy was commonly recommended in the
1980s[8,12], but less frequent testing intervals were more
commonly recommended in the early 1990s[7]. The com-
bination of air-contrast barium enema and flexible sig-
moidoscopy is often recommended as a reasonable
alternative to colonoscopy. Guidelines differentiate
between patients who undergo a pre-operative colonos-
copy from those who do not: those who do not are recom-
mended to undergo a colonoscopy within a year of
surgery.
Variations in the practice patterns in the use of post-oper-
ative colonoscopy in the United States has been well doc-
umented [13-19]. In these studies, the use of colonoscopy
varied across age groups, socio-economic status, race, lev-
els of comorbidities, tumor location, stage, and SEER
region. There is limited direct data on the use of colonos-
copy in patients under age 65, who comprise a significant
proportion of colorectal cancer patients and who have
potentially the most to gain from early detection of a
recurrence or new cancer.
Examining practice patterns under different health care
systems can provide further insights into the cause of prac-
tice variations. Canada has a similar standard of medical
care but a markedly different system for funding health
care. In contrast to the United States, Canadians are cov-
ered by universal, public health care insurance and do not
incur out of pocket expenses for medically necessary phy-
sician or hospital services. Therefore, access in Canada is
not limited by ability to pay for health care, but could be
limited by availability of local resources.
The purpose of this study was to examine the use of post-
operative colonoscopy in patients who had undergone a
potentially curative resection for colorectal cancer
between 1983 and 1995. Specifically, we wished to deter-
mine the likelihood that a patient would undergo a post-
operative colonoscopy and whether this was affected by
patient, tumour, treatment or surgeon characteristics.
Based on previous research, we hypothesized that patients
who were younger, who had more advanced tumours
(Stage C: regional lymph node metastases) and who
resided in urban areas would be more likely to undergo at
least one post-operative colonoscopy. We also wished to
examine the impact of gender, tumour site, type of sur-
gery, preoperative colonoscopy and whether or not the
surgeon performed colonoscopy on the probability of
undergoing a post-operative colonoscopy. We examined
whether practice patterns differed between the two large
metropolitan areas, Edmonton and Calgary, where the
majority of specialized medical care in the province is pro-
vided and that would be expected to have similar practice
patterns. We also determined whether those who did not
undergo a colonoscopy underwent a flexible sigmoidos-
copy. Because we could not determine whether patients
underwent a barium enema, by measuring flexible sig-
moidoscopy we could provide an estimate of the maxi-
mum number of people who underwent alternative
complete colonic evaluation.
Methods
In this historical cohort study, we linked the records of
Alberta residents who had undergone a potentially cura-
tive resection for a first primary colorectal cancer identi-
fied from the Alberta Cancer Registry to Alberta Health &
Wellness administrative databases to determine the utili-
zation of post-operative colonoscopy. Additional patient,
tumor and treatment data was obtained by primary chart
review of provincial cancer clinic charts. This study was
approved by the Conjoint Health Research Ethics Board of
the University of Calgary and the Research Ethics Com-
mittee of the Alberta Cancer Board.
Subjects
We included Alberta residents aged at least 30 years diag-
nosed with a first adenocarcinoma of the colon or rectumBMC Cancer 2004, 4 http://www.biomedcentral.com/1471-2407/4/14
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(International Classification of Diseases in Oncology
topography codes C18.0 – C18.9, C19.9 or C20.9)
between January 1, 1983 and December 31, 1995 who
underwent a potentially curative resection and survived at
least 270 days after their surgery. We excluded those with
distant metastases, those who had a prior diagnosis of a
non-colorectal invasive neoplasm, and those who were
not eligible for coverage by the Alberta Health Care Insur-
ance Plan (AHCIP) at the time of their diagnosis. We also
excluded those with known inflammatory bowel disease,
familial adenomatous polyposis or known hereditary can-
cer syndrome. Finally we excluded those who underwent
a total proctocolectomy as their primary surgery, those
with insufficient clinical information available to deter-
mine eligibility criteria and those who could not be suc-
cessfully linked to Alberta Health & Wellness databases.
Subjects were initially selected from the Alberta Cancer
Registry. Following exclusion of those who did not meet
eligibility criteria based on information available in the
Cancer Registry, a random sample of patients was selected
for full chart review. We used a sampling strategy that
would result in approximately 4000 eligible subjects, but
weighted towards those diagnosed in the late 1980s and
early 1990s, the time period during which surveillance
guidelines were changing and also a group who we
believed would have the most complete follow-up data
available. Therefore, all patients diagnosed from January
1, 1988 to December 31, 1992 were included and a 40%
random sample stratified by year of diagnosis and place of
residence was chosen from subjects diagnosed in the
remaining years.
Data Sources and Variables
Alberta Cancer Registry
Coverage of registration for most cancers is at or above
95%[20]. The Registry is linked monthly to Alberta Vital
Statistics to detect the date and cause of death of regis-
trants. Key demographic, tumor and treatment data is
recorded routinely at the time of registration. The distance
a patient resided from the nearest colonoscopy site was
determined using the latitude and longitude of the
patient's postal code of residence and postal code of the
colonoscopy site[21].
AHCIP Physicians Payments' Database
This database was the primary source of data on colono-
scopies and flexible sigmoidoscopies performed on
patients prior to and after resection of their tumor. This
database includes all payments for insured health care
services provided to AHCIP registrants by in-province
physicians. In Alberta during the years included in this
study, fee-for-service physicians provided all endoscopy
services. The date that a patient was no longer eligible for
coverage by AHCIP was obtained from the AHCIP Popu-
lation Registry.
All records for flexible sigmoidoscopy (code 01.24B) and
colonoscopy (01.22) performed on patients from one
year prior to the date of the diagnosis to March 31, 2000
were obtained. A specific billing code for performing an
endoscopy via a stoma does not exist. Endoscopists tend
to use the flexible sigmoidoscopy or colonoscopy fee
codes depending on the extent of the exam. Only colono-
scopies occurring before or on the date of diagnosis of
cancer recurrence or new cancer were included as post-
operative colonoscopies. The indication for the procedure
is not recorded.
Alberta Cancer Clinics' Clinical Charts
All clinic charts maintained on a subject at any of the six
provincial cancer clinics were reviewed to determine
tumor stage (which is not present in the Registry data-
base), type and date of primary operation, surgeon and
disease outcomes. Tumor stage was determined from the
review of the operative and pathology reports from a
patient's primary surgery along with any other available
clinical data (consult notes, diagnostic imaging reports). A
surgeon was classified as performing colonoscopy if any
procedure report of a colonoscopy performed by that sur-
geon was found in any patients chart (not just the charts
of patients the surgeon operated on). A patient was con-
sidered to have undergone adjuvant there if they under-
went pre-operative or post-operative chemotherapy or
radiotherapy.
Analysis
Missing data
Because of the multiple, often overlapping data sources,
complete data were available for most of the variables of
interest. However, information was missing on tumor
stage for 53 patients and place of residence for 9. Forty-six
of the 53 patients with missing tumor stage were assigned
the stage recorded in their chart by their primary surgeon
or oncologist. The remaining missing values for stage and
place of residence were imputed based on their distribu-
tion in the rest of the study sample
Statistical Analysis
A survival analysis approach was taken for examining the
risk of patients undergoing a first post-operative colonos-
copy and to examine factors influencing this risk. Patients
were censored at the date of any of the following events:
diagnosis of cancer recurrence, loss of AHCIP coverage, or
death. Kaplan-Meier estimates of the survival function
were created. Differences in the survival function between
different groups were examined graphically with Kaplan-
Meier curves and tested using the Wald test. Next,
extended Cox regression models were fit to examine theBMC Cancer 2004, 4 http://www.biomedcentral.com/1471-2407/4/14
Page 4 of 11
(page number not for citation purposes)
independent effects of each predictor variable and to fur-
ther examine confounding and interaction. Standard Cox
models assume that the risk (hazard) of an event for one
group is proportional to the risk of an event in the other
group throughout the time period of interest. However, it
was obvious from the examination of the Kaplan-Meier
curves that the proportional hazards assumption was not
met as often changes in the hazard of undergoing a post-
operative colonoscopy only became apparent after the
first 12 post-operative months (for example, see figure 1).
We therefore used extended Cox regression methodol-
ogy[22]. The survival history for each individual was split
at the 12th post-operative month. Models were then fit
which generated two sets of coefficients for each variable
included in the model: the first reflecting its effect over the
first 12 months and the second its effect over the subse-
quent 48 months. Variables were first examined in univar-
iate and multivariate models of related variables (i.e.
tumor characteristics). Variables significant at the 0.05
level were then included in multivariate models. The
Akaike Information Criterion was used to assess the good-
ness of fit of models[23]. The statistical significance of
parameters was tested using the Wald test. Robust esti-
mates of the variance of each parameter were derived
based on the method of Lin and Wei[24]. All analyses
were performed using Stata version 7[25].
Results
From the Alberta Cancer Registry, 11494 patients with
colorectal cancer were identified. Based on eligibility
information available from the Registry, 3553 were
excluded. Of the remaining 7941 potentially eligible
Time to first post-operative colonoscopy stratified by time period of diagnosis Figure 1
Time to first post-operative colonoscopy stratified by time period of diagnosis. Kaplan-Meier survival curves of time 
to first post-operative colonoscopy for patients diagnosed from 1983 – 1989 and 1990 – 1995. A divergence in the curves at 12 
months is consistent with increased use of colonoscopy for post-operative surveillance.
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Table 1: Characteristics of patients included and excluded in full chart review
Included Excluded 
n (%) 1,924 (40%) 2,884 (60%)
Sex: males 1,066 (55.4%) 1,546 (53.6%)
Age, years (mean) 67.4 67.4
Urban residence 1,628 (84.6%) 2,431 (84.3%)
Tumor site colon 1,388 (72.1) 2,128 (73.8%)
Table 2: Study sample characteristics and univariate associations with post-operative colonoscopy
Variable Sample distribution Probability undergoing colonoscopy P value
Sex
Male 2188 (56%) 0.57
Female 1730 (44%) 0.63 0.021
Age group
30 – 54 559 (14%) 0.75
55 – 69 1567 (40%) 0.74
70 – 79 1161 (30%) 0.50
> 80 631 (16%) 0.28 <0.0001
Place of residence
Urban 582 (15%) 0.60
Rural 3336 (85%) 0.60 0.6
Tumor site
Colon 2891 (74%) 0.54
Rectum 1027 (26%) 0.72 <0.0001
Stage
1 876 (22%) 0.65
2 1880 (48%) 0.57
3 1162 (30%) 0.63 0.0001
Pre-operative colonoscopy
Yes 1646 (42%) 0.69
No 2272 (58%) 0.54 <0.0001
Procedure type
Resection 3363 (86%) 0.62
Abdominoperineal resection 555 (14%) 0.47 <0.0001
Site of surgery
Calgary 1270 (32%) 0.58
Edmonton 1733 (44%) 0.63
Other Major City 607 (15%) 0.60
Other 308 (8%) 0.55 <0.0001
Adjuvant therapy
Yes 1049 (27%) 0.72
No 2869 (93%) 0.57 <0.0001
Cancer clinic visits
None 1691 (43%) 0.52
1 – 4 1434 (37%) 0.63
≥ 5 793 (20%) 0.74 <0.0001
Surgeon performs 
colonoscopies
Yes 1838 (47%) 0.68
No 2080 (53%) 0.54 <0.0001BMC Cancer 2004, 4 http://www.biomedcentral.com/1471-2407/4/14
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patients, 5057 were selected for chart review. Table 1 com-
pares basic demographic and tumor characteristics of
those who were and were not selected for chart review. Of
those who underwent chart review, 3918 patients met all
inclusion criteria and were included in the final sample,
1826 diagnosed from 1983 – 1989 and 2092 diagnosed
from 1990 – 1995. The main reasons for exclusion based
on Cancer Registry information were previous or synchro-
nous non-colorectal cancer (n = 1147), not eligible for
Alberta Health Care coverage (n = 215) and ineligible
tumor morphology (n = 162). The main reasons for exclu-
sion based on information obtained at chart review were
distant metastases (n = 620), endoscopic polypectomy
only treatment (n = 140), and tumor not resected (n =
133).
The demographic, tumor and treatment characteristics of
the sample are shown in Table 2. The proportions of
patients residing within 10 kilometers, 10 – 99 kilometers
and 100 kilometers or more from the nearest colonoscopy
site were 68%, 18% and 14%, respectively. The five-year
survival for the entire sample was 66% and was 83%, 68%
and 48% for those with tumor stage 1, 2 and 3, respec-
tively. Of the 1829 deaths, 1105 (60%) were due to color-
ectal cancer, 116 (6%) due to other new non-colorectal
cancers and 608 (33%) due to non-cancer causes.
First Post-Operative Colonoscopy
At least one colonoscopy was performed within five years
of the primary surgery in 1979 (51%) patients. Patients
who were diagnosed from 1990 – 1995 were more likely
to undergo a colonoscopy than those diagnosed from
1983 – 1989 (Figure 1: 5-year cumulative probability 0.65
vs. 0.55, P < 0.0001). The difference in colonoscopy rates
between the two groups is primarily due to an increased
likelihood of those diagnosed from 1990 – 1995 undergo-
ing a colonoscopy at around the 12-month mark.
Table 2 also shows the five-year probability of undergoing
a colonoscopy for different patient, tumor, treatment and
surgeon characteristics. Tumor site (rectal versus colonic)
was not associated with the probability of undergoing a
post-operative colonoscopy after adjusting for the effect of
type of surgical procedure (resection with reanastomosis
versus abdominoperineal resection).
The influence of some of these factors on the probability
of a patient undergoing a post-operative colonoscopy
depended on the time period that the person was diag-
nosed. For those diagnosed from 1983 – 1989, women
were less likely than men to undergo a post-operative
colonoscopy (5-year cumulative probability 0.49 versus
0.61). However, for those diagnosed in the later time
period, no difference was apparent (0.66 versus 0.65).
Place of residence was a significant predictor of the prob-
ability of undergoing a colonoscopy for those diagnosed
in the early time period but not in the later. Pre-operative
colonoscopy and location (city) of surgery were signifi-
cant predictors in both time periods. Figures 2 &3 show
Kaplan-Meier curves of time to first post-operative colon-
oscopy for patients who underwent surgery in Calgary and
Edmonton stratified by time period of diagnosis. In the
early time period, patients in Calgary were much less
likely to undergo a colonoscopy than patients in Edmon-
ton (0.49 vs. 0.57), but this was no longer the case in the
later time period (0.66 vs. 0.63). This change is due to the
marked increase use of colonoscopy at the 12-month
post-surgery mark in those patients who underwent sur-
gery in Calgary (Figure 2). In contrast, there was little
change in the use of colonoscopy in Edmonton over the
time period of this study (Figure 3).
To further explore potential confounding and interaction
among the variables, extended Cox proportional hazard
models were fit. In these models the data was split into
two time periods: post-operative months 1 – 12 and 13 –
60. The final model produces one set of hazard ratios
reflecting the association between the variable and the
probability of undergoing a colonoscopy for the first 12
months following surgery and a second set for the next 48
months. The results of the model are shown in Tables 3
and 4. Table 3 shows the results for variables that are not
associated with a time period of diagnosis interaction and
Table 4 for those that are. The majority of the hazard ratios
shown in Tables 3 and 4 do not substantially differ from
those obtained from univariate models (data not shown).
However, the hazard ratios associated with site of surgery,
specifically those associated with the comparison of Cal-
gary to Edmonton did change. When site of surgery was
examined alone, patients in Calgary diagnosed from 1990
– 1995 were shown to have a hazard ratio of 1.31 com-
pared with Edmonton during the follow-up months 13 –
60. However, in the multivariable model this hazard ratio
is now 1.01. This change occurs only when the cancer
clinic visits variable is added to the model. Patients who
underwent surgery in Calgary on average had more cancer
clinic visits than patients who underwent surgery in
Edmonton (mean 3.7 vs. 1.9).
Post-Operative Flexible Sigmoidoscopy
Only 224 (11.6%) patients who did not undergo a post-
operative colonoscopy underwent a post-operative sig-
moidoscopy. A similar proportion (10.6%) of those who
did undergo a post-operative colonoscopy also under-
went a flexible sigmoidoscopy prior to their colonoscopy.
For those who did not undergo a post-operative colonos-
copy, undergoing a post-operative flexible sigmoidoscopy
was not associated with their age or sex, tumor stage,
number of clinic visits, whether they underwent a pre-
operative colonoscopy or whether their surgeon per-BMC Cancer 2004, 4 http://www.biomedcentral.com/1471-2407/4/14
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formed colonoscopies. There was, however, a strong asso-
ciation with procedure type and where they underwent
surgery. Only 3 (0.9%) who underwent an abdominoper-
ineal resection underwent a flexible sigmoidoscopy com-
pared with 2221 (13.8%) of those who underwent a
resection. Those who underwent their surgery in smaller
cities (Other city) were twice as likely to undergo a flexible
sigmoidoscopy (22.7%) than those who underwent their
surgery in either of the two large cities or elsewhere (p <
0.0005).
Discussion
In this study, we showed that there have been important
variations in the use of colonoscopy following potentially
curative surgery in Alberta. Furthermore, there have been
significant changes in the use of the test over the past two
decades. Based on the existing literature, we had hypothe-
sized that younger patients, those with more advanced
tumors and those residing in urban areas would be more
likely to undergo at least one post-operative colonoscopy.
When examining the Kaplan-Meier curves for time to first
post-operative colonoscopy, a clear change in the hazard
of undergoing a colonoscopy is seen at around the one-
year mark following surgery. This is most consistent with
increased use for surveillance purposes, as one would not
expect such a dramatic increase use in colonoscopy at one
year following the date of surgery just for the investigation
of symptoms. Furthermore, when examining the effect of
different variables on the probability of undergoing a
Time to first post-operative colonoscopy for Edmonton patients Figure 2
Time to first post-operative colonoscopy for Edmonton patients Kaplan Meier curve of time to first post-operative 
colonoscopy for patients who underwent primary cancer surgery in Edmonton, stratified by time period of diagnosis. No 
change in practice patterns are evident from the curves for the two time periods.
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post-operative colonoscopy, many of the differences are
only seen or become most pronounced at around the one-
year mark. This suggests that differences between groups
are primarily due to differences in surveillance practices.
Just over 50% of all patients underwent at least one post-
operative colonoscopy, which is in keeping with testing
rates reported in Medicare patients by Cooper[26]. How-
ever, testing did increase in the 1990s, as the probability
of a patient diagnosed in the 1990s undergoing at least
one post-operative colonoscopy was 0.65 compared with
0.55 for a patient diagnosed in the 1980s. This difference
becomes apparent at the one-year post-operative mark,
thus indicating that differences in use between the two
time periods is due to changes in surveillance practices.
Several other variables were shown to be associated with
the probability of undergoing a first post-operative
colonoscopy, including age, undergoing a preoperative
colonoscopy, type of surgery, number of cancer clinic
visits, whether the surgeon performs colonoscopies and
where the patient underwent their cancer surgery. Surveil-
lance guidelines do not base recommendations for screen-
ing on the majority of the variables that were found to be
associated with post-operative colonoscopy in this study.
Certainly some of these variables would be expected to be
associated with the likelihood of undergoing a post-oper-
ative colonoscopy, even if they were not explicitly stated
in surveillance recommendations. Older patients, espe-
cially those with significant comorbidities, would have
less to gain from surveillance as their survival may be
Time to first post-operative colonoscopy for Calgary patients Figure 3
Time to first post-operative colonoscopy for Calgary patients Kaplan Meier curve of time to first post-operative 
colonoscopy for patients who underwent primary cancer surgery in Calgary, stratified by time period of diagnosis. A major 
change in practice patterns is evident as patients diagnosed from 1990 – 1995 are much more likely to undergo a post-opera-
tive colonoscopy, primarily due to increased use of colonoscopy at one year after surgery.
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more limited by their other medical conditions. Unfortu-
nately, we could not accurately measure comorbidities,
especially in a longitudinal fashion over the course of the
patients follow-up, to determine what impact
concomitant medical problems had on the likelihood of
undergoing surveillance in more elderly patients.
Our data did not support our second hypothesis that
those with more advanced tumors would be more likely
to undergo a colonoscopy. Although we saw some differ-
ences between those with different stage tumors in the
probability of undergoing a colonoscopy this was not a
linear trend. Those with Stage A and C tumors were more
likely to undergo a colonoscopy than those with Stage B.
This association was not seen in the multivariate analysis.
A pre-operative colonoscopy would not be expected to
affect the likelihood of undergoing a post-operative one,
although it would be expected to affect the timing. In gen-
eral, guidelines have recommended a colonoscopy within
one year for those patients who did not undergo a pre-
operative colonoscopy. However, patients who did not
undergo a pre-operative colonoscopy were less likely to
undergo a post-operative colonoscopy within the first five
post-operative years and the expected pattern of undergo-
ing an early post-operative colonoscopy was not seen. In
fact, in those who did not undergo a pre-operative colon-
Table 3: Extended Cox Regression Model: First post-operative colonoscopy variables not associated with time period of diagnosis
Month 1 – 12 Month 13 – 60
HR (95% CI) HR (95% CI)
Age Group (vs 30 – 54)
55 – 69 0.77 (0.63 – 0.93) 0.98 (0.81 – 1.19)
70 – 69 0.48 (0.38 – 0.60) 0.53 (0.43 – 0.66)
80+ 0.14 (0.10 – 0.21) 0.29 (0.21 – 0.38)
Procedure type
APR vs Resection 0.29 (0.22 – 0.40) 0.71 (0.59 – 0.86)
Cancer clinic visits (vs 0)
1 – 4 1.09 (0.92 – 1.30) 1.39 (1.19 – 1.63)
≥ 5 1.13 (0.92 – 1.39) 1.69 (1.39 – 2.06)
Surgeon performs colonoscopy
Yes vs No 1.85 (1.59 – 2.15) 1.38 (1.21 – 1.59)
Table 4: Extended Cox Regression Model: first post-operative colonoscopy variables associated with time period of diagnosis
Month 1 – 12 Month 13 – 60
HR (95% CI) HR (95% CI)
Sex (M vs F)
1983 – 1989 0.88 (0.69 – 1.11) 1.24 (1.01 – 1.53)
1990 – 1995 0.92 (0.76 – 1.11) 0.87 (0.73 – 1.05)
Pre-operative colonoscopy (yes vs no)
1983 – 1989 1.52 (1.20 – 1.91) 1.57 (1.29 – 1.93)
1990 – 1995 0.88 (0.73 – 1.06) 1.46 (1.22 – 1.75)
Site of surgery (vs. edmonton)
1983 – 1989
Calgary 0.56 (0.43 – 0.74) 0.61 (0.48 – 0.78)
Other major city 0.71 (0.50 – 1.02) 0.69 (0.50 – 0.95)
Other 0.74 (0.46 – 1.20) 0.66 (0.46 – 0.96)
1990 – 1995
Calgary 0.54 (0.43 – 0.68) 1.08 (0.87 – 1.33)
Other major city 1.06 (0.82 – 1.37) 1.34 (1.04 – 1.73)
Other 0.78 (0.53 – 1.15) 0.97 (0.66 – 1.42)BMC Cancer 2004, 4 http://www.biomedcentral.com/1471-2407/4/14
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oscopy there was little change in the Kaplan-Meier curve
at the one-year mark suggesting that there was little use of
surveillance colonoscopy in this group.
Patients may not undergo a pre-operative colonoscopy if
they presented with a complicated tumor, either perfo-
rated or obstructed. Alternatively they may not undergo a
colonoscopy if the tumor is visualized by barium enema
or is located in the rectum and visualized by sigmoidos-
copy or proctoscopy. However, these patients, potentially,
have the most to gain from a post-operative colonoscopy
to detect metachronous polyps or cancers. Preferential use
of barium enema could be the result of physician prefer-
ences or lack of local colonoscopy resources.
One of the most interesting differences in this study is that
seen between patients who were treated in Edmonton and
Calgary. These two cities have the two largest cancer clin-
ics and the largest number of surgical and cancer special-
ists. Therefore, one might anticipate quite similar practice
patterns. However, there were marked differences in the
use and timing of post-operative colonoscopy. Patients
diagnosed in the 1980s who underwent their cancer sur-
gery in Edmonton were much more likely to undergo a
post-operative colonoscopy than those patients who
underwent their surgery in Calgary. A possible reason for
the higher frequency of post-operative colonoscopy in
Edmonton was the establishment of a postoperative sur-
veillance colonoscopy service at the Cross Cancer Institute
circa 1980. A similar program did not exist in Calgary.
However, in the 1990s, this difference was no longer
apparent. There had been a marked change in the use of
colonoscopy in Calgary, essentially all due to increased
use at the one-year post-operative mark. In contrast, no
change was seen in the use of colonoscopy in Edmonton
over the 13 years of this study.
Differences between these two cities could also be due to
differences in colonoscopy capacity, differences in physi-
cian practice patterns or a combination of the two. In gen-
eral, the endoscopy resources, in terms of endoscopists
and endoscopy sites, would have been similar int the two
cities. However, recent work has shown that in the early
1990's, only one-half the number of colonoscopies were
performed in Calgary as were performed in Edmonton
despite a similar population[27]. This difference had
markedly narrowed by 2000. Therefore, if this trend was
also present in the 1980's, it is reasonable to assume that
colon cancer patients in Calgary had less access to colon-
oscopy, presumably due to different physician practice
patterns.
Our third hypothesis was that those residing in rural areas
would be less likely to undergo colonoscopy. However,
we could not find evidence supporting this. This may be
due to marked increase in colonoscopy resources outside
of the two major urban areas[27]. The majority of patients
resided within 10 km of the nearest colonoscopy site, and
only 14% lived more than 100 km away.
We could not collect data on other post-operative testing,
such as CEA, barium enemas or CT scans. The existing
administrative databases, either do not or incompletely
include records on these tests. Therefore, we cannot deter-
mine whether patients underwent alternative tests, such as
double-contrast barium enema, instead of colonoscopy or
if not undergoing a colonoscopy was associated with not
undergoing other post-operative surveillance testing, such
as CEA. An alternative to colonoscopy for complete
colonic examination is the combination of flexible sig-
moidoscopy and air-contrast barium enema. We did
measure flexible sigmoidoscopy use and found that only
11.6% of patients who did not undergo a post-operative
colonoscopy underwent a flexible sigmoidoscopy. There-
fore, flexible sigmoidoscopy alone or combined with a
barium enema was not commonly used as an alternative
to colonoscopy.
The value of post-operative surveillance, including colon-
oscopy continues to be debated. No randomized control-
led trial has been conducted specifically addressing the
issue of colonoscopic surveillance. However, three pub-
lished randomized studies of intensive follow-up found
no benefit from a follow-up program that included regu-
lar colonoscopic examination[10,11,28]. Kjeldsen et
al[10] in a Danish trial found no benefit to an intensive
follow-up regimen that included colonoscopy every six
months. However, all patients underwent a post-operative
colonoscopy prior to entry into the study. In a Finnish
trial, Makela et al[28] randomized patients to intensive
versus conventional follow-up and could not demonstrate
a survival benefit or increased resectability despite recur-
rences being identified earlier in the intensive surveillance
group. Intensive follow-up included yearly colonoscopy.
However, regular colonic testing also occurred in the con-
ventional follow-up, including annual air-contrast bar-
ium enemas and fecal occult blood testing. Finally,
Schoemaker et al[11] included fecal occult blood testing
every three months for two years and then every six
months for three years in their conventional follow-up
group. The intensive follow-up group underwent yearly
colonoscopy. Seventy-two colonoscopies were performed
on the 158 patients in the conventional treatment group
compared with 577 in the 167 patients in the intensive
treatment group. The authors noted that most meta-
chronous and locally recurrent carcinomas in each group
were detected by means other than colonoscopy. A statis-
tically significant survival advantage could not be demon-
strated for the intensive follow-up group.BMC Cancer 2004, 4 http://www.biomedcentral.com/1471-2407/4/14
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Conclusions
In conclusion we found important variations in the use of
colonoscopy following potentially curative colorectal can-
cer surgery inpatients diagnosed in the province of Alberta
from 1983 to 1997. The majority of factors that were asso-
ciated with these variations would not have been pre-
dicted based on prevailing surveillance guidelines.
Overall, there was evidence of increased use of at least one
post-operative colonoscopy over the time course of the
study. Given that surveillance colonoscopy will remain a
recommended surveillance strategy, even in the absence
of RCT level evidence supporting its efficacy, it is impera-
tive that those physicians managing patients with colorec-
tal cancer endeavor to insure that all patients who may
potentially benefit have access to the procedure.
Improved communication between those who provide
the majority of the post-operative care and those who pro-
vide endoscopic services may be required.
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